Neoplasms News

Mesa Highlights Guideline Updates in Myeloproliferative Neoplasms - OncLive



OncLive
 
Mesa Highlights Guideline Updates in Myeloproliferative Neoplasms 
OncLive
Specifically in the guidelines, the needs of patients who progress on these myeloproliferative neoplasms (MPNs) are addressed. Although many patients with PV or ET can be treated with phlebotomy and aspirin, physicians must be aware that there is a ...

 


Dr. Wong Discusses Monoclonal Antibodies in Plasma Cell Neoplasms - OncLive



OncLive
 
Dr. Wong Discusses Monoclonal Antibodies in Plasma Cell Neoplasms 
OncLive
Sandy Wong, MD, assistant professor, Division of Hematology/Oncology, UCSF School of Medicine, discusses monoclonal antibodies in plasma cell neoplasms. NEOD001 is an anti-amyloid fibril monoclonal antibody that augments the macrophage system in ...

and more » 


Immunomodulators and risk of malignant neoplasms in patients with RA - Pharmacy Today, American Pharmacists Association, pharmacist.com



Immunomodulators and risk of malignant neoplasms in patients with RA 
Pharmacy Today, American Pharmacists Association, pharmacist.com
A register-based, prospective cohort study out of Sweden sought to determine whether treatment with tocilizumab, abatacept, rituximab, or tumor necrosis factor inhibitors (TNFis) affects the risk of malignant neoplasms among patients with rheumatoid ...

 


A 3-year retrospective review of mortality in women of reproductive age in a tertiary health facility in Port ... - Dove Medical Press



A 3-year retrospective review of mortality in women of reproductive age in a tertiary health facility in Port ... 
Dove Medical Press
Infectious diseases, diseases of the circulatory system, and malignant neoplasms were the major causes of death among WRA, with maternal deaths accounting for approximately a quarter. Public health programs educating women on safer sex practices, ...

 


Biologics Not Linked to Higher Cancer Risk in RA - Medscape



Medscape
 
Biologics Not Linked to Higher Cancer Risk in RA 
Medscape
The authors conclude, "In this study, to our knowledge one of the largest observational studies on the risk of malignant neoplasms in RA patients treated with bDMARDs to date, we found that the overall risk of developing cancer among patients with RA ...

 


Plasma Cell Neoplasm Treatment Market Evolving Industry Trends and Key Insights by 2025 - Medgadget (blog)



Plasma Cell Neoplasm Treatment Market Evolving Industry Trends and Key Insights by 2025 
Medgadget (blog)
Plasma cells are responsible for the development of antibodies in the immune system. Abnormal growth of plasma cells takes place in bone marrow and these cells start forming tumors, resulting in plasma cell neoplasms. Plasma neoplasm cells produce M ...

 


Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and Management - Cancer Network



Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and Management 
Cancer Network
Neuroendocrine tumors (NETs) are widely distributed neoplasms described as epithelial tumors with predominantly neuroendocrine differentiation that share a common phenotype. Regardless of primary site, these tumors have a propensity to metastasize to ...

 


Genetic test shows promise for identifying pancreatic cysts at high risk for cancer - Healio



Genetic test shows promise for identifying pancreatic cysts at high risk for cancer 
Healio
... which are ?highly specific for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs).? Additionally, they found 6% of specimens showed TP53/PIK3CA/PTEN alterations, which are ?associated with advanced neoplasia.?.

 


Nation's Experts in Hematologic Malignancies to Discuss Latest ... - PR Newswire (press release)



Nation's Experts in Hematologic Malignancies to Discuss Latest ... 
PR Newswire (press release)
NCCN 12th Annual Congress: Hematologic Malignancies? will be held October 6 - 7, 2017 in San Francisco, California, and features a new Nursing Forum.

and more » 


Stanford staffer jumps back into research with help of NIH grant - Stanford Medical Center Report



Stanford Medical Center Report
 
Stanford staffer jumps back into research with help of NIH grant 
Stanford Medical Center Report
Krishnan decided to focus her current research on looking for blood platelet gene markers in patients with myeloproliferative neoplasms, or MPNs, which are blood cancers that cause too many white or red blood cells or platelets to be produced in the body.